Literature DB >> 32729619

Comparing two measures of sleep depth/intensity.

Magdy Younes1, Paula K Schweitzer2, Kara S Griffin2, Robert Balshaw3, James K Walsh2.   

Abstract

STUDY
OBJECTIVES: To compare delta spectral power (delta) and odds ratio product (ORP) as measures of sleep depth during sleep restriction with placebo or a drug that increases delta.
METHODS: This is a secondary analysis of data from a study of 41 healthy participants randomized to receive placebo or gaboxadol 15 mg during sleep restriction. Participants underwent in-laboratory sleep studies on two baseline, four sleep restriction (5-h), and two recovery nights. Relation between delta or ORP and sleep depth was operationally defined as the degree of association of each metric to the probability of arousal or awakening occurring during the next 30 s (arousability).
RESULTS: ORP values in wake, N1, N2, N3, and REM were significantly different. Delta differed between both N2 and N3 and other sleep stages but not between wake and N1 or N1 and REM. Epoch-by-epoch and individual correlations between ORP and delta power were modest or insignificant. The relation between ORP and arousability was linear across the entire ORP range. Delta also changed with arousability but only when delta values were less than 300 μV2. Receiver-operating-characteristic analysis found the ability to predict imminent arousal to be significantly greater with ORP than with log delta power for all experimental conditions. Changes in ORP, but not log delta, across the night correlated with next-day physiologic sleep tendency.
CONCLUSIONS: Compared to delta power, ORP is more discriminating among sleep stages, more sensitive to sleep restriction, and more closely associated with arousability. This evidence supports ORP as a measure of sleep depth/intensity. © Sleep Research Society 2020. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com.

Entities:  

Keywords:  ORP; delta power; odds ratio product; sleep intensity; slow-wave activity

Mesh:

Year:  2020        PMID: 32729619     DOI: 10.1093/sleep/zsaa127

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  7 in total

1.  Association of a novel EEG metric of sleep depth/intensity with attention-deficit/hyperactivity, learning, and internalizing disorders and their pharmacotherapy in adolescence.

Authors:  Anna Ricci; Susan L Calhoun; Fan He; Jidong Fang; Alexandros N Vgontzas; Duanping Liao; Edward O Bixler; Magdy Younes; Julio Fernandez-Mendoza
Journal:  Sleep       Date:  2022-03-14       Impact factor: 6.313

2.  Adherence Index: sleep depth and nocturnal hypoventilation predict long-term adherence with positive airway pressure therapy in severe obstructive sleep apnea.

Authors:  Magdy K Younes; Andrew E Beaudin; Jill K Raneri; Beth J Gerardy; Patrick J Hanly
Journal:  J Clin Sleep Med       Date:  2022-08-01       Impact factor: 4.324

3.  Relation between arousability and outcome of upper airway stimulation in the Stimulation for Apnea Reduction (STAR) Trial.

Authors:  Jason L Yu; Magdy Younes
Journal:  J Clin Sleep Med       Date:  2021-04-01       Impact factor: 4.062

4.  Maturational trajectories of non-rapid eye movement slow wave activity and odds ratio product in a population-based sample of youth.

Authors:  Anna Ricci; Fan He; Jidong Fang; Susan L Calhoun; Alexandros N Vgontzas; Duanping Liao; Magdy Younes; Edward O Bixler; Julio Fernandez-Mendoza
Journal:  Sleep Med       Date:  2021-05-11       Impact factor: 4.842

5.  Characteristics and reproducibility of novel sleep EEG biomarkers and their variation with sleep apnea and insomnia in a large community-based cohort.

Authors:  Magdy Younes; Ali Azarbarzin; Michelle Reid; Diego R Mazzotti; Susan Redline
Journal:  Sleep       Date:  2021-10-11       Impact factor: 6.313

6.  Sleep architecture based on sleep depth and propensity: patterns in different demographics and sleep disorders and association with health outcomes.

Authors:  Magdy Younes; Bethany Gerardy; Allan I Pack; Samuel T Kuna; Cecilia Castro-Diehl; Susan Redline
Journal:  Sleep       Date:  2022-06-13       Impact factor: 6.313

7.  Revisiting level II sleep studies in the era of COVID-19: a theoretical economic decision model in patients with suspected obstructive sleep apnea.

Authors:  Najib T Ayas; Rachel Jen; Brett Baumann
Journal:  Sleep Sci Pract       Date:  2021-07-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.